defective drug lawyers Archives - Medical Malpractice Lawyers

FDA Responds To Evidence Of Possible Association Between Autism And Acetaminophen Use During Pregnancy

September 24, 2025

The U.S. Food and Drug Administration announced on September 22, 2025 that it initiated the process for a label change for acetaminophen (Tylenol and similar products) to reflect evidence suggesting that the use of acetaminophen by pregnant women may be associated with an increased risk of neurologi[...]

Federal Appellate Court Distinguishes Certain Drug Rebates From Unlawful Kickbacks

April 7, 2025

Regeneron Pharmaceuticals, Inc. manufactures Eylea. Eylea is one of just a few drugs approved by the Food and Drug Administration (FDA) for treating an ophthalmological condition called neovascular age-related macular degeneration, also known as wet AMD. Eylea is a “buy and bill” drug un[...]

GSK Settles Zantac Lawsuits For $2.2 Billion

October 12, 2024

GSK plc (LSE/NYSE: GSK) announced on October 9, 2024 that it has reached agreements with 10 plaintiff firms who together represent 93% (approximately 80,000) of the Zantac (ranitidine) state court product liability cases pending against GSK in the United States. Under these agreements, GSK will make[...]

Two Generic Drug Companies Agree To Pay $305M To Settle Price Fixing, Other Claims

March 4, 2024

The United States Department of Justice announced on August 21, 2023 deferred prosecution agreements resolving criminal antitrust charges against Teva Pharmaceuticals USA, Inc. (“Teva”) and Glenmark Pharmaceuticals Inc., USA (“Glenmark”). As part of the agreements, both compa[...]

How Pharmaceutical Companies Game The Patent System And Earn Billions At Patients’ Safety And Expense

January 31, 2023

How Pharmaceutical Companies Game The Patent System: The New York Times reported on how pharmaceutical companies legally abuse the patent system and hospital management software to earn billions from their patents that are expiring on their cash-cow drugs. By using lawsuits and settlement practices [...]

Drug Company Issues Recall Of Certain Lots Of Erectile Dysfunction Drug And Depression Drug Due To “Product Mix-Up”

December 11, 2020

AvKARE, Pulaski, TN announced on December 9, 2020 that it is voluntarily recalling one lot of Sildenafil 100 mg tablets and one lot of Trazodone 100mg tablets to the consumer level. These products have been recalled “due to a product mix-up of the listed two separate products inadvertently pac[...]

High Levels Of Probable Carcinogen Detected In Specific Lots Of Metformin

March 31, 2020

Valisure, an online pharmacy currently licensed in 38 states and an analytical laboratory that is ISO 17025 accredited by the International Organization for Standardization (“ISO”) that is dedicated to preventing anyone from suffering adverse effects from low quality medications, announced on Ma[...]

California Appellate Court Finds Pharmaceutical Company Not Liable For Physician’s Malpractice In Drug Trial

January 12, 2018

The Court of Appeal of the State of California Second District Division Five (“California Appellate Court”) held in its unpublished opinion filed on January 3, 2018 that a pharmaceutical company conducting a trial of a new drug owed no duty to a study participant to intervene in his medi[...]

First Tylenol Liver Damage Trial Ends In Defense Verdict

October 29, 2015

On October 16, 2015, a jury in New Jersey absolved Johnson and Johnson’s McNeil Consumer Healthcare subsidiary from liability to the plaintiff for her liver damage allegedly caused by taking Tylenol (acetaminophen), after a three-week trial. The 55-year-old plaintiff had alleged that the manu[...]

Obama Administration Responds To Recent SCOTUS Generic Drug Decision

July 11, 2013

As we discussed in our June 27, 2013 blog entitled “U.S. Supreme Court Decision Shields Generic Drug Manufacturers,” the U.S. Supreme Court (“SCOTUS”) held in its 5-4 decision filed on June 24, 2013 that personal injury claims against generic drug manufacturers under des[...]

U.S. Supreme Court Decision Shields Generic Drug Manufacturers

June 27, 2013

In its 5-4 decision filed on June 24, 2013, the Supreme Court of the United States (“Supreme Court”) held that personal injury claims against generic drug manufacturers under design-defect consumer protection state laws that turn on the adequacy of a drug’s warnings are pre-empted [...]

Tag: defective drug lawyers